Vapotherm invented HFNC and now sells an advanced form of HFNC that provides high flow at a high velocity, rapidly flushing the dead space in the limited time between breaths when respiratory rates ...

Respiratory care specialist Vapotherm raised $56 million in an initial public offering of 4 million shares, priced at the low end of the range at $14. The Exeter, New Hampshire-based company plans to ...

Infinium Medical, through its Infinium Veterinary division will be exclusively distributing Vapotherm VET 2.0 high-velocity respiratory therapy systems. This partnership allows us to provide ...

Increased capacity anticipated to scale capital production by up to 20X above pre-COVID-19 pandemic levels At maximum capacity, increased production could create up to 350 manufacturing jobs in New ...

Partnership enables Vapotherm to build a robust and secure solution 80% faster than the standard development timeline to meet data visualization and device management goals for HVT ® 2.0 and future ...

"High Flow Oxygen Therapy Devices Market"The global high-flow oxygen therapy devices market is estimated to grow at a CAGR of 2.31% during the forecast period from 2025 to 2032. The global High-Flow ...

The global high-flow oxygen therapy devices market is estimated to grow at a CAGR of 2.31% during the forecast period from 2025 to 2032. The global High-Flow Oxygen Therapy (HFOT) Devices Market is ...